Pharmaceutical industry executives, speaking confidentially, paint a frank picture of the rationale behind the price of medication available to people with multiple sclerosis.
source https://www.sciencedaily.com/releases/2019/11/191125173501.htm
source https://www.sciencedaily.com/releases/2019/11/191125173501.htm
Comments
Post a Comment